Market Place
Sourcing Support
All News #Library
Biotech
Enterobiotix Completes Phase 2A Trial Enrollment For EBX-102-02
10 Mar 2026 //
GLOBENEWSWIRE
Enterobiotix Reports Positive Phase 2 Results For EBX-102-02
08 Jan 2026 //
PHARMIWEB
EnteroBiotix Shows Positive Liver Cirrhosis Data at EASL 2025
13 May 2025 //
GLOBENEWSWIRE
EnteroBiotix Shares Positive IBS-C Data at Digestive Disease Week
06 May 2025 //
GLOBENEWSWIRE
EnteroBiotix Reports Positive Phase 2a Results for IBS Treatment
18 Mar 2025 //
GLOBENEWSWIRE
EnteroBiotix Completes EBX-102-02 Study Recruitment in IBS
18 Nov 2024 //
GLOBENEWSWIRE
EnteroBiotix Completes Ph 2 Study Recruitment of EBX-102-02 in IBS
18 Nov 2024 //
GLOBENEWSWIRE
EnteroBiotix Announces Positive EBX-102 Results in Liver Cirrhosis
11 Nov 2024 //
GLOBENEWSWIRE
EnteroBiotix Initiates Phase 2 Study of EBX-102-02 in Patients with IBS
03 Apr 2024 //
GLOBENEWSWIRE
EnteroBiotix Initiates Phase 2 study of microbiome drug EBX-102
28 Mar 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.